As a Principal at Gilmartin Group, Matt Bacso provides expertise in Investor Relations, Corporate Communications, Capital Markets, and Business Development to help his clients create durable shareholder value. He tailors his work-scope for the unique needs and objectives of his clients across the medical device, healthcare, and biopharma industries. Matt is a CFA with over a decade of capital markets experience as an equity research analyst and corporate advisor focused in the Healthcare sector. Prior to joining the Gilmartin Group, Matt was the head of investor relations and corporate development at Inogen, Inc. Before Inogen, Matt worked as an equity research analyst covering medical devices at Piper Jaffray. Prior to Piper Jaffray, Matt worked as an equity research analyst covering pharmaceutical outsourcing, healthcare distribution, and pharmacy benefit management at William Blair.
Gilmartin Group is a strategic advisory firm that provides comprehensive service offerings throughout the lifespan of their client companies. At Gilmartin, the company leverages cross-discipline experience and a team approach to deliver results. Gilmartin recognizes that no two companies are alike, and the company tailors its work-scope for the unique needs and objectives of its clients. The ways in which Gilmartin partners with its clients can vary – building customized investor relations programs for emerging growth companies, large caps or micro-caps; acting as an outside strategic consultant; and helping private companies navigate Wall Street and create communications strategies. Gilmartin’s track record of success is fueled by their unparalleled experience and the strength of their relationships among actionable investors and industry veterans.